Tag: Healthcare Research Award

Patrick McGinnis | Medicine and Dentistry | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Patrick McGinnis — University of Maryland SOM

Researcher Information
Researcher Patrick McGinnis
Affiliation University of Maryland SOM
Country United States
Scopus ID 59216505900
Documents 9
Citations 5
h-index 1
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0002-3820-5613

Patrick McGinnis is a researcher affiliated with the University of Maryland SOM in the United States, with a documented research profile in the subject area of Medicine and Dentistry. The available bibliographic profile identifies Scopus Author ID 59216505900 and reports 9 documents, 5 citations, and an h-index of 1. [1] The researcher is also associated with the ORCID identifier 0000-0002-3820-5613, providing a persistent identifier for scholarly works and professional research activity. [2]

This article presents a structured academic recognition profile for the Innovative Research Award in connection with the World Science Awards. The information is organized around the researcher’s documented bibliographic indicators, subject area, scholarly profile, research contributions, research impact, and suitability for recognition.

Abstract

The Innovative Research Award profile recognizes the documented scholarly activity of Patrick McGinnis, affiliated with the University of Maryland SOM and working within the broad subject area of Medicine and Dentistry. Available Scopus information records 9 documents, 5 citations, and an h-index of 1 under Scopus Author ID 59216505900. [1] These indicators provide a bibliographic basis for describing the researcher’s current indexed publication and citation record. The researcher’s ORCID identifier, 0000-0002-3820-5613, further supports persistent identification of scholarly activities. [2] Within the context of the World Science Awards, the Innovative Research Award can be considered in relation to documented research activity, subject-area relevance, publication output, and evidence of scholarly contribution.

Keywords

  • Innovative Research Award
  • Patrick McGinnis
  • Medicine and Dentistry
  • Medical Research
  • Research Innovation
  • Scholarly Publications
  • Research Impact
  • World Science Awards
  • Scopus Author Profile
  • ORCID

Introduction

Academic recognition in medicine and dentistry may consider multiple dimensions of scholarly activity, including research output, publication records, citation performance, subject relevance, and the demonstrated contribution of research to a field. Bibliographic databases such as Scopus provide structured indicators that can assist in documenting publication and citation activity, while ORCID provides a persistent researcher identifier that helps distinguish individual scholars and connect their scholarly works. [1] [2]

Patrick McGinnis is identified in the supplied research information as being affiliated with the University of Maryland SOM and associated with Medicine and Dentistry. The available profile reports a Scopus record containing 9 documents and 5 citations, with an h-index of 1. [1] These figures describe the indexed bibliographic record available for the specified Scopus author profile and should be interpreted as indicators of documented scholarly activity rather than as a complete assessment of research quality.

Research Profile

The research profile of Patrick McGinnis is situated within the subject classification of Medicine and Dentistry. According to the supplied Scopus information, the author profile is associated with 9 indexed documents and 5 citations, resulting in an h-index of 1. [1] The profile is further connected to the persistent ORCID identifier 0000-0002-3820-5613. [2]

Research Indicator Documented Value
Affiliation University of Maryland SOM
Country United States
Subject Area Medicine and Dentistry
Scopus Documents 9
Citations 5
h-index 1
Scopus Author ID 59216505900
ORCID 0000-0002-3820-5613

Research Contributions

The supplied information establishes a documented body of indexed scholarly activity associated with Patrick McGinnis. The record of 9 Scopus-indexed documents provides evidence of publication activity within the researcher’s indexed profile. [1] The association with Medicine and Dentistry places this work within a broad clinical and biomedical research context.

A precise assessment of individual research contributions requires examination of the titles, abstracts, methodologies, findings, co-authorship patterns, publication venues, and full-text research outputs. Because those details are not included in the supplied dataset, specific scientific findings or individual publication-level contributions are not attributed here. This approach avoids inferring research achievements that are not directly documented in the available profile information.

  • Documented scholarly activity in the Medicine and Dentistry subject area.
  • A Scopus-indexed publication record comprising 9 documents.
  • A recorded citation count of 5 in the supplied Scopus profile.
  • Persistent researcher identification through ORCID.

Publications

The supplied profile records 9 documents under Scopus Author ID 59216505900. [1] The available input does not provide the individual publication titles, journal names, publication dates, DOI identifiers, or article-level citation counts. Accordingly, no publication-specific bibliographic details are assigned without verification against the researcher’s indexed record.

For a complete publication assessment, the individual documents should be reviewed for authorship, research topic, publication venue, peer-review status, DOI information, citation activity, and relevance to Medicine and Dentistry. Such a review would provide a more detailed basis for evaluating the nature and influence of the researcher’s scholarly contributions.

Research Impact

The supplied Scopus profile reports 5 citations and an h-index of 1 for Patrick McGinnis. [1] These metrics provide quantitative indicators of the citation activity associated with the indexed author record. Citation counts can vary over time as databases are updated, and they should therefore be interpreted in conjunction with publication quality, field-specific citation practices, research contribution, and other qualitative evidence.

The h-index of 1 indicates that at least one indexed publication in the specified profile has received at least one citation according to the supplied record. [1] The metric alone does not establish the scientific quality or societal importance of individual research outputs. A balanced research-impact assessment should combine quantitative bibliometric evidence with examination of the substantive contribution of the underlying work.

Award Suitability

Patrick McGinnis may be considered for the Innovative Research Award based on the documented presence of scholarly research activity in Medicine and Dentistry, an indexed Scopus publication record, and a persistent ORCID research identity. [1] [2] The available record establishes a measurable publication and citation profile that can form part of an award evaluation.

Award suitability should, however, be determined using the complete evaluation criteria established by the World Science Awards. The supplied information does not independently document the originality, methodological significance, translational value, societal impact, or specific innovations associated with the researcher’s individual publications. Consequently, these characteristics should be verified through the submitted research materials and supporting evidence before a final award decision is made. [3]

Evaluation Dimension Available Evidence
Research Field Relevance Medicine and Dentistry
Publication Activity 9 Scopus-indexed documents
Citation Activity 5 citations
Bibliometric Indicator h-index 1
Researcher Identification ORCID 0000-0002-3820-5613
Award Context World Science Awards

Conclusion

Patrick McGinnis is an identified researcher affiliated with the University of Maryland SOM and associated with the Medicine and Dentistry subject area. The supplied Scopus profile documents 9 documents, 5 citations, and an h-index of 1, while the ORCID record provides a persistent identifier for the researcher. [1] [2]

In the context of the Innovative Research Award, these indicators provide a documented starting point for evaluating research activity. A comprehensive award assessment should additionally consider the originality, quality, relevance, reproducibility, and broader significance of the underlying research outputs. The available information supports a neutral academic profile while avoiding conclusions that cannot be established from the supplied bibliographic data.

References

  1. Elsevier. (n.d.). Scopus author details: Patrick McGinnis, Author ID 59216505900. Scopus.
    https://www.scopus.com/pages/authors/59216505900
  2. ORCID. (n.d.). ORCID record: Patrick McGinnis, ORCID iD 0000-0002-3820-5613. ORCID.
    https://orcid.org/0000-0002-3820-5613
  3. World Science Awards. (n.d.). World Science Awards: Official Website.
    https://worldscienceawards.com/

Matthew Garoufalis | Health Professions | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Matthew Garoufalis
PFCS, PC
Matthew Garoufalis
Affiliation PFCS, PC
Country United States
Scopus ID 6506510183
Documents 26
Citations 301
h-index 6
Subject Area Health Professions
Event World Science Awards
ORCID 0000-0002-3649-9136

The Innovative Research Award recognizes researchers whose scholarly work demonstrates originality, interdisciplinary collaboration, and measurable contributions to scientific knowledge. Matthew Garoufalis, affiliated with PFCS, PC, has established a research profile in the field of Health Professions through peer-reviewed publications, scholarly citations, and continued participation in evidence-based healthcare research. His publication metrics indicate sustained academic engagement and contributions to professional practice and clinical science.[1]

Abstract

Matthew Garoufalis is an academic researcher whose work is associated with Health Professions and evidence-based clinical practice. His publication record, citation performance, and interdisciplinary scholarly activities demonstrate continued engagement in advancing healthcare knowledge. With twenty-six indexed publications, three hundred and one citations, and an h-index of six, his research profile reflects measurable scientific influence and continued contribution to professional healthcare literature.[1][2]

Keywords

  • Health Professions
  • Clinical Research
  • Evidence-Based Practice
  • Healthcare Innovation
  • Scientific Publications
  • Research Impact
  • Patient Care
  • World Science Awards

Introduction

Research within the Health Professions plays a critical role in improving patient outcomes, healthcare quality, and evidence-based clinical decision-making. Scientific investigations conducted by healthcare professionals contribute to advances in diagnosis, treatment methodologies, rehabilitation, and preventive care. Continued publication and dissemination of research findings strengthen both academic knowledge and clinical practice across healthcare systems.[3]

Research Profile

According to the available bibliometric information, Matthew Garoufalis has published twenty-six Scopus-indexed documents, accumulated three hundred and one citations, and attained an h-index of six. These objective indicators demonstrate sustained participation in scholarly research and measurable recognition within the academic community through peer-reviewed scientific publications.[1]

  • Affiliation: PFCS, PC.
  • Country: United States.
  • Primary discipline: Health Professions.
  • Indexed publications: 26.
  • Total citations: 301.
  • Scopus h-index: 6.

Research Contributions

The available publication record reflects contributions to healthcare research through peer-reviewed scientific studies addressing professional practice and clinical knowledge. Research within Health Professions supports improvements in patient care, healthcare delivery, interdisciplinary collaboration, and the application of scientific evidence to professional practice. Such scholarly activities contribute to continuous advancement in modern healthcare systems.[2][3]

Publications

Matthew Garoufalis has contributed to the scientific literature through peer-reviewed publications indexed in internationally recognized bibliographic databases. The documented publication portfolio demonstrates ongoing scholarly communication and participation in collaborative academic research within the Health Professions discipline.[1]

  • Peer-reviewed journal articles.
  • Clinical and healthcare research.
  • Evidence-based professional practice.
  • Indexed scholarly publications.

Research Impact

Bibliometric indicators such as publication output, citation frequency, and h-index are commonly used to evaluate scholarly influence. The available metrics associated with Matthew Garoufalis demonstrate measurable academic visibility through twenty-six publications, three hundred and one citations, and an h-index of six. These indicators reflect continued participation in scientific communication and contribution to evidence-based healthcare research.[1]

Award Suitability

Based on the documented academic profile, Matthew Garoufalis demonstrates characteristics commonly considered during evaluation for research recognition, including peer-reviewed publication, measurable citation performance, interdisciplinary healthcare research, and sustained scholarly activity. The available bibliometric evidence supports consideration for recognition through the World Science Awards, while final selection remains subject to the official evaluation procedures established by the award committee.[1][2]

Conclusion

Matthew Garoufalis has established a scholarly profile characterized by continued publication activity, measurable citation impact, and contributions to Health Professions research. His academic work supports evidence-based healthcare and reflects ongoing participation in scientific communication. The available bibliometric information provides an objective summary of his research achievements and professional contributions within the healthcare research community.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Matthew Garoufalis, Author ID 6506510183. Scopus.
    https://www.scopus.com/pages/authors/6506510183
  2. ORCID. (n.d.). ORCID Record: Matthew Garoufalis.
    https://orcid.org/0000-0002-3649-9136
  3. Institute of Medicine. Health Professions Education: A Bridge to Quality.
    DOI: https://doi.org/10.17226/10681
  4. World Science Awards. (n.d.). Official Award Information.
    https://worldscienceawards.com/

Ved Pal | Pharmacology | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Ved Pal
Affiliation ISF College of Pharmacy, Moga, Punjab
Country India
Scopus ID 59895257200
Documents 3
Citations 5
h-index 1
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-3523-1469

Ved Pal
ISF College of Pharmacy, Moga, Punjab, India

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate sustained commitment to scientific advancement, innovation, and academic excellence. VED PAL, affiliated with ISF College of Pharmacy, Moga, Punjab, has established an academic profile in the field of pharmacology through research contributions, professional engagement, and participation in internationally recognized scholarly platforms.[1]

Abstract

VED PAL is an academic researcher associated with ISF College of Pharmacy, Moga, Punjab, India. His scholarly interests are centered on pharmacology, an interdisciplinary field that integrates pharmaceutical sciences, biomedical research, and therapeutic innovation. His academic profile reflects ongoing engagement with scientific publication, research dissemination, and professional development within the pharmaceutical sciences.[1][2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Research, Biomedical Science, Therapeutics, Academic Research, Scientific Publications, Innovation, World Science Awards, Healthcare Research.

Introduction

Pharmacology remains one of the most significant scientific disciplines supporting healthcare innovation through the study of medicines, therapeutic mechanisms, and biological responses. Researchers working in this field contribute toward improving evidence-based healthcare, advancing pharmaceutical technologies, and supporting interdisciplinary scientific collaboration. Academic recognition programs acknowledge these contributions by evaluating research quality, scholarly productivity, and scientific impact using internationally recognized academic indicators.[2][3]

Research Profile

VED PAL is affiliated with ISF College of Pharmacy in Punjab, India, where his academic interests align with pharmacological research and pharmaceutical sciences. His scholarly identity is represented through internationally recognized researcher identifiers, including a Scopus Author ID and an ORCID profile, supporting transparency in research attribution and academic visibility.[1][4]

Research Contributions

Research activities in pharmacology typically involve investigations related to drug discovery, therapeutic evaluation, pharmacodynamics, pharmacokinetics, toxicology, and clinical relevance. Through academic participation and publication activities, VED PAL contributes to the broader scientific dialogue supporting pharmaceutical research and evidence-driven healthcare. Such contributions encourage collaboration between academic institutions and the scientific community while promoting responsible research practices.[2][5]

Publications

The researcher’s scholarly output is indexed through the Scopus author profile associated with Author ID 59895257200. Publication records, citation data, and bibliographic information are maintained through recognized academic indexing systems, allowing researchers and institutions to monitor scientific productivity and collaboration.[1]

Research Impact

Research impact extends beyond publication volume and includes scientific influence, collaboration, knowledge dissemination, and practical application of research findings. International researcher identifiers such as ORCID and Scopus improve research discoverability, strengthen scholarly communication, and facilitate accurate attribution across academic databases. These systems support transparent evaluation of academic achievements within the global research ecosystem.[1][4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating commitment to scholarly excellence, ethical research practices, scientific innovation, and meaningful contributions within their discipline. Based on the available academic identifiers, institutional affiliation, and specialization in pharmacology, VED PAL represents a researcher whose profile aligns with the objectives of recognizing ongoing scientific engagement and academic development through the World Science Awards.[5]

Conclusion

VED PAL’s academic profile reflects continued participation in pharmaceutical research and international scholarly communication. Through institutional affiliation, recognized researcher identifiers, and engagement with pharmacological sciences, the profile illustrates a commitment to research integrity, scientific advancement, and professional development. Recognition through the Innovative Research Award highlights the importance of sustained contributions to contemporary scientific research while encouraging future innovation within the pharmaceutical sciences.[1][5]

References

  1. Elsevier. (n.d.). Scopus Author Details: VED PAL, Author ID 59895257200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59895257200
  2. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
    DOI: https://doi.org/10.1038/s41573-021-00234-4
  3. World Health Organization. (n.d.). Research for Health.
    https://www.who.int
  4. ORCID. (n.d.). ORCID Record: 0000-0003-3523-1469.
    https://orcid.org/0000-0003-3523-1469
  5. World Science Awards. (n.d.). Award Evaluation and Recognition Framework.
    https://worldscienceawards.com/

Rushani Cameron | Medicine and Dentistry | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Rushani Cameron
Affiliation SUNY Downstate Health Sciences University, Brooklyn, New York, USA
Country United States
Scopus ID 60539313500
Documents 2
Subject Area Orthopedic Surgery, Sports Medicine, Outcomes Research, Medicine and Dentistry
Event World Science Awards
ORCID 0009-0003-0166-1505

Rushani Cameron
SUNY Downstate Health Sciences University, Brooklyn, New York, USA

Rushani Cameron is a physician-scientist in training whose academic work centers on orthopedic surgery, sports medicine, cartilage restoration, hip preservation, arthroscopy, and clinical outcomes research. As a Doctor of Medicine candidate at SUNY Downstate Health Sciences University, Cameron has developed an active research portfolio through collaborations with NYU Langone Health and Maimonides Medical Center. Her work integrates evidence-based clinical investigation with patient-centered outcome assessment and has resulted in multiple peer-reviewed publications and national scientific presentations.[1]

Abstract

Rushani Cameron has established an emerging academic profile through clinical research in orthopedic surgery and sports medicine. Her investigations evaluate long-term surgical outcomes, graft survivorship, mental health influences on orthopedic recovery, cartilage restoration, and hip preservation. Through collaborations with leading orthopedic researchers, she has contributed to peer-reviewed literature and numerous presentations at internationally recognized conferences, demonstrating a strong commitment to evidence-based clinical research.[2]

Keywords

Orthopedic Surgery, Sports Medicine, Hip Arthroscopy, Cartilage Restoration, Meniscal Allograft Transplantation, Outcomes Research, Orthopedic Research, Medical Education, Clinical Research, Evidence-Based Medicine.

Introduction

Orthopedic surgery increasingly depends upon high-quality clinical evidence to improve patient outcomes and optimize surgical decision-making. Cameron’s academic activities focus on generating clinically relevant evidence addressing sports medicine, hip preservation, cartilage repair, and patient-reported outcomes. Her work reflects interdisciplinary collaboration across academic medical centers and demonstrates an early commitment to translational orthopedic research.[3]

Research Profile

  • Doctor of Medicine Candidate at SUNY Downstate Health Sciences University.
  • Former Orthopedic Research Fellow at NYU Langone Health.
  • Orthopedic Research Scholar at Maimonides Medical Center.
  • Research interests include sports medicine, hip preservation, arthroscopy, cartilage restoration, and clinical outcomes.
  • Recipient of multiple academic honors, including Best Researcher Award, Best Paper Award, and Innovative Research Award.

Research Contributions

Cameron’s research emphasizes long-term evaluation of orthopedic procedures using retrospective cohort studies, registry analyses, and patient-reported outcomes. Her published investigations have examined corticosteroid injections before meniscal transplantation, chondrocyte implantation outcomes, ankle fracture readmissions, posterior tibial slope, and survivorship following meniscal allograft transplantation. Additional ongoing work explores hip arthroscopy, surgical technology, mental health, and cartilage restoration.[4]

Publications

  • Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Meniscal Allograft Transplantation. DOI: 10.3390/surgeries7020075
  • Patient Comorbidities Drive 90-Day Emergency Department Revisits and Readmissions After Trimalleolar Ankle Fracture ORIF. DOI: 10.5435/JAAOS-D-25-01063
  • Preoperative Corticosteroid Injection and Outcomes Following Chondrocyte Implantation. DOI: 10.3390/surgeries7010040
  • Posterior Tibial Slope and Meniscal Allograft Survivorship. DOI: 10.1002/ksa.70460

Research Impact

The research portfolio demonstrates active participation in clinically meaningful orthopedic investigations addressing patient safety, surgical outcomes, graft survivorship, and long-term functional recovery. Cameron has presented research at major professional organizations including AAOS, AOSSM, ISHA, COS, EOA, OSET, and NMA, illustrating broad dissemination of research findings within the orthopedic community.[5]

Award Suitability

Based on her documented academic record, peer-reviewed publications, leadership activities, and extensive participation in national orthopedic conferences, Rushani Cameron demonstrates characteristics commonly associated with emerging investigator recognition. Her multidisciplinary research, commitment to medical education, and contributions to orthopedic outcomes research support consideration for early-career research recognition within academic medicine.[6]

Conclusion

Rushani Cameron represents an emerging clinician-investigator whose scholarly work spans orthopedic surgery, sports medicine, and outcomes research. Her publication record, conference presentations, leadership roles, and continued engagement in translational orthopedic investigations demonstrate a sustained commitment to advancing evidence-based patient care and medical research.

External Links

References

  1. Elsevier. Scopus Author Details: Rushani Cameron, Author ID 60539313500.
    https://www.scopus.com/authid/detail.uri?authorId=60539313500
  2. Cameron RK et al. Surgeries. 2026.
    https://doi.org/10.3390/surgeries7020075
  3. SUNY Downstate Health Sciences University Curriculum Vitae.
  4. NYU Langone Health Orthopedic Research Portfolio.
  5. American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, Clinical Orthopaedic Society, International Society for Hip Arthroscopy Conference Abstracts.
  6. Curriculum Vitae and documented academic achievements supplied by the researcher.

Jabra Zarka | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Jabra Zarka
Affiliation Mayo Clinic
Country United States
Scopus ID 57217183871
Documents 13
Citations 222
h-index 7
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0001-8668-6741

Jabra Zarka

Mayo Clinic, United States

The Best Researcher Award recognizes distinguished scholarly achievement, scientific productivity, and meaningful contributions to the advancement of knowledge. Jabra Zarka, affiliated with Mayo Clinic in the United States, has established a notable research profile in the fields of medicine and dentistry through peer-reviewed publications, interdisciplinary collaborations, and measurable scientific impact. The research metrics associated with this profile, including publications, citations, and h-index values, indicate sustained engagement in scientific inquiry and academic dissemination.[1]

Abstract

This article presents an academic overview of Jabra Zarka’s scholarly profile in recognition of nomination for the Best Researcher Award at the World Science Awards. The assessment considers bibliometric indicators, publication activity, scientific influence, and contributions to medical research. The available metrics indicate an active and productive research career characterized by interdisciplinary engagement and measurable citation impact.[1]

Keywords

Best Researcher Award; Medical Research; Bibliometrics; Scientific Impact; Scopus Author Profile; Research Excellence; Citation Analysis; Medicine and Dentistry; Scholarly Publications; Academic Recognition.

Introduction

Academic awards play an important role in recognizing individuals whose research contributes significantly to scientific advancement and societal development. Bibliometric indicators, including publication counts and citation metrics, are widely used to evaluate research performance and scholarly influence.[2] Jabra Zarka’s scientific profile demonstrates sustained contributions to medicine and dentistry through peer-reviewed research outputs and academic collaboration.

Research Profile

Jabra Zarka is affiliated with Mayo Clinic, one of the internationally recognized medical research institutions in the United States. The research profile indexed in Scopus identifies 13 scholarly documents that have collectively received 222 citations, resulting in an h-index of 7.[1] These indicators suggest a meaningful level of academic engagement and the dissemination of research findings within the scientific community.

  • Affiliation with Mayo Clinic, United States.
  • Research specialization in Medicine and Dentistry.
  • Indexed publications and measurable citation impact.
  • Active scholarly presence through international dissemination.

Research Contributions

The scientific contributions of Jabra Zarka are reflected through publications addressing contemporary issues in medicine and healthcare. The research outputs have contributed to scientific understanding and have attracted citations from subsequent studies, demonstrating relevance and influence within the academic community.[3]

  • Production of peer-reviewed scientific articles.
  • Contribution to interdisciplinary medical research.
  • Participation in evidence-based scientific investigations.
  • Dissemination of knowledge through indexed journals.

Publications

The publication record indexed under the Scopus Author ID demonstrates scholarly productivity and continuous engagement with scientific communication. Publications in internationally indexed journals contribute to the visibility and accessibility of research findings and facilitate knowledge transfer among researchers and practitioners.[1]

  1. Peer-reviewed articles in medicine and dentistry.
  2. Collaborative scientific publications with interdisciplinary authors.
  3. Research outputs indexed in major academic databases.

Research Impact

Research impact is commonly assessed through bibliometric indicators and citation analyses that provide evidence of scientific influence and knowledge dissemination.[2] With 222 citations and an h-index of 7, the scholarly profile of Dr. Jabra Zarka reflects a measurable and growing academic impact within the field of medicine and dentistry.

Award Suitability

The Best Researcher Award seeks to recognize researchers who demonstrate scientific excellence, sustained scholarly productivity, and measurable impact. Based on the available bibliometric indicators and documented publication record, Jabra Zarka’s academic profile aligns with the principles of research recognition promoted by the World Science Awards.[4]

Conclusion

Jabra Zarka has developed a notable scholarly profile characterized by research productivity, citation influence, and contributions to medicine and dentistry. The documented bibliometric indicators and publication achievements provide evidence of scientific engagement and support recognition through the Best Researcher Award at the World Science Awards. Continued research activity and dissemination are expected to further strengthen this academic profile.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Jabra Zarka, Author ID 57217183871. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57217183871
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
    https://doi.org/10.1073/pnas.0507655102
  3. Garfield, E. (2006). The history and meaning of the journal impact factor. Journal of the American Medical Association.
    https://doi.org/10.1001/jama.295.1.90

Muhammad Noman | Health Professions | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Muhammad Noman
The University of Faisalabad, Faisalabad, Pakistan
Muhammad Noman
Affiliation The University of Faisalabad
Country Pakistan
Scopus ID 59599793100
Documents 2
Citations 5
h-index 1
Subject Area Microbiology, Hematology, Health Professions
Event World Science Awards

Muhammad Noman is a Pakistani academic and medical laboratory technologist specializing in molecular diagnostics, hematology, microbiology, histopathology, bio-chemistry, clinical pathology, infectious disease surveillance, and laboratory quality management systems. He currently serves as Senior Lecturer in Medical Laboratory Sciences at The University of Faisalabad and has accumulated extensive experience in laboratory diagnostics, biosafety management, and pandemic-related healthcare operations.[1] His professional contributions include academic teaching, molecular diagnostic testing, operation of Biosafety Level-II and Biosafety Level-III laboratories, and participation in public health initiatives related to COVID-19 and infectious disease control.[2]

Abstract

Muhammad Noman has established a multidisciplinary professional profile in medical laboratory sciences through his involvement in molecular diagnostics, infectious disease surveillance, hematology, microbiology, and laboratory biosafety systems. His work spans academic instruction, laboratory management, diagnostic operations, and healthcare research with emphasis on COVID-19, hepatitis C virus prevalence, dengue fever, and thalassemia-related investigations.[3] He has participated in laboratory quality management training programs, biosafety initiatives, and international academic collaborations while contributing to research publications focused on epidemiology and diagnostic methodologies.[4]

Keywords

Medical Laboratory Sciences, Molecular Diagnostics, Hematology, Histopathology, Microbiology, Clinical Pathology, Biosecurity, Biosafety, Infectious Diseases, COVID-19, Laboratory Quality Management, Disease Surveillance, Molecular Epidemiology, Public Health, Healthcare Research.

Introduction

The advancement of medical laboratory sciences has become increasingly important in the detection, monitoring, and prevention of infectious and non-communicable diseases. Professionals working in diagnostic laboratories contribute significantly to healthcare systems by ensuring accurate laboratory analyses, biosafety compliance, and disease surveillance activities.[5] Muhammad Noman has developed professional expertise across several branches of pathology and laboratory sciences, including microbiology, hematology, immunology, molecular biology, and laboratory biosafety systems.

His professional activities include work in Biosafety Level-II and Level-III laboratory environments, COVID-19 PCR testing, blood banking, laboratory quality assurance, and academic teaching. In addition to laboratory diagnostics, he has participated in workshops and professional development activities related to infectious disease management, laboratory risk management, and clinical pathology systems.[5]

Research Profile

Muhammad Noman completed his Master of Science in Medical Laboratory Sciences from Riphah International University Lahore between 2021 and 2023. Prior to this, he obtained a Bachelor of Science (Honours) degree in Medical Laboratory Technology from Government College University Faisalabad. He also completed specialized technical education in operation theater technology and clinical biochemistry.[1]

His professional experience includes appointments as Lecturer in Medical Laboratory Sciences at The University of Faisalabad, Blood Bank Technologist at Mujahid Hospital Faisalabad, Medical Laboratory Technologist at Allied Hospital Faisalabad, and laboratory staff member at Al-Khidmat Diagnostic Center. His work has involved laboratory diagnostics, infectious disease testing, laboratory supervision, and operation of clinical laboratory systems during pandemic response activities.[2]

Research Contributions

Muhammad Noman’s research activities focus on laboratory diagnostics, epidemiology, and public health-related investigations. His scholarly contributions include studies on hepatitis C virus prevalence, COVID-19 diagnostic methodologies, dengue fever hematological profiling, and mortality-associated factors in thalassemia patients.[3]

He has also contributed to literature associated with CRISPR/Cas technologies and molecular diagnostic approaches in modern biomedical sciences. His involvement in laboratory biosafety and quality management programs demonstrates integration between academic research and clinical laboratory operations.[2]

Publications

  1. Arif, A., Noor-ul-Ain, Munir, A., Noman, M., Munawar, N., Abdelsalam, K., Qari, S. H., & Ahmad, A. (2023). Global Patent Landscape in CRISPR/Cas. In CRISPRized Horticulture Crops, Elsevier.
  2. Noman et al. (2023). Demographic Insights into Hepatitis-C Virus Prevalence among Internally Displaced Persons (IDPs) and Native Populations of Punjab, Pakistan. The Research of Medical Review.
  3. Noman et al. (2025). Role of Immunochromatographic Techniques in the Diagnosis of COVID-19. Indus Journal of Bioscience Research.
  4. Noman et al. (2025). Differential Diagnosis of Different Etiological Markers of COVID-19 among Lab Personals. The Research of Medical Science Review.
  5. Noman et al. (2025). Clinical and Hematological Profiling of Dengue Fever: Impact of Age, Gender, and Comorbidities on Disease Severity. Indus Journal of Bioscience Research.
  6. Noman et al. (2025). Investigate the Mortality, Morbidity and Factors Associated in Thalassemia Patients in Faisalabad, Pakistan. Indus Journal of Bioscience Research.

Research Impact

The research and laboratory activities undertaken by Muhammad Noman contribute to healthcare diagnostics, biosafety awareness, and disease surveillance initiatives within Pakistan’s healthcare and academic sectors. His involvement in molecular diagnostics and infectious disease testing has supported laboratory preparedness during COVID-19 response activities.[3]

Through academic instruction and laboratory supervision, he has participated in the training and development of medical laboratory technology students while maintaining involvement in quality assurance and biosafety systems. His work reflects integration between laboratory sciences, public health surveillance, and healthcare education.[1]

Award Suitability

Muhammad Noman demonstrates qualifications relevant to recognition in the field of medical laboratory sciences and healthcare diagnostics due to his combined contributions to laboratory management, molecular diagnostics, biosafety operations, and academic instruction. His professional engagement with BSL-II and BSL-III laboratory systems, participation in COVID-19 testing operations, and research publications in infectious disease diagnostics indicate substantial involvement in healthcare laboratory sciences.[5]

His participation in national and international workshops, laboratory quality management training, and professional memberships further reflects ongoing engagement with biomedical and laboratory science advancements. These contributions align with the objectives of academic and healthcare research recognition programs.[4]

Conclusion

Muhammad Noman’s academic and professional profile reflects interdisciplinary involvement in medical laboratory sciences, molecular diagnostics, infectious disease surveillance, and laboratory biosafety systems. His combination of clinical laboratory experience, research participation, and academic teaching contributes to the advancement of diagnostic healthcare practices and laboratory sciences education in Pakistan.[2] His continued contributions to research, laboratory management, and healthcare diagnostics support his recognition within biomedical and medical laboratory science communities.

References

  1. Professional academic curriculum vitae and educational background of Muhammad Noman, including qualifications in Medical Laboratory Sciences and Medical Laboratory Technology.
  2. Professional experience records including appointments at The University of Faisalabad, Allied Hospital Faisalabad, Mujahid Hospital, and Al-Khidmat Diagnostic Center.
  3. Research publications associated with infectious disease diagnostics, COVID-19 investigations, dengue fever profiling, and thalassemia-related studies.
  4. Professional certifications and memberships related to biosafety, laboratory quality management systems, and molecular diagnostics training.
  5. World Health Organization. (n.d.). Laboratory biosafety guidance related to infectious diseases and diagnostic systems.

Shuwen Han | Immunology and Microbiology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Shuwen Han
Affiliation Huzhou Central Hospital
Country China
Scopus ID 56089782700
Documents 117
Citations 2,291
h-index 27
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0001-6180-9565

Shuwen Han
Tarim University, China

Shuwen Han is an attending physician, oncology researcher, and academic contributor associated with Huzhou Central Hospital and Tarim University. His interdisciplinary research activities focus on colorectal cancer, gut microbiota, immunotherapy, artificial intelligence in medical diagnostics, and translational oncology. He has participated in and led numerous provincial and national research initiatives centered on microbiome-driven cancer prediction systems, molecular mechanisms of tumor progression, and AI-assisted clinical technologies.[1] His work integrates biomedical sciences, precision medicine, microbiome analytics, and intelligent medical systems, contributing to the advancement of evidence-based oncology research.[2]

Abstract

Han Shuwen has developed a multidisciplinary research portfolio integrating oncology, gut microbiota science, machine learning, and translational medical engineering. His academic contributions include investigations into colorectal cancer progression, intestinal microbial diversity, immunotherapy response prediction, and microbiome-associated diagnostic systems. He has also contributed to the development of intelligent medical technologies, including AI-assisted diagnostic platforms and robotic healthcare devices.[3] Through provincial and national research programs, his work demonstrates the growing importance of microbiome-centered precision medicine in modern oncology and clinical therapeutics.

Keywords

Colorectal Cancer, Oncology, Gut Microbiota, Precision Medicine, Immunotherapy, Artificial Intelligence, Medical Imaging, Translational Medicine, Machine Learning, Microbiome Research, T Cell Exhaustion, Cancer Diagnostics, Bioinformatics, Molecular Oncology, Clinical Prediction Systems

Introduction

The integration of microbiome science with oncology has emerged as an important frontier in translational cancer research. Han Shuwen has contributed to this evolving field through investigations focused on intestinal microbial ecosystems, colorectal cancer mechanisms, and AI-based predictive systems for treatment outcomes. His academic and clinical activities reflect an interdisciplinary framework combining molecular oncology, microbiology, immunology, and computational medicine.[4]

As an attending physician and academic researcher, he has participated in projects examining chemotherapy-associated diarrhea, tumor immunology, colorectal cancer resistance pathways, and microbiome-assisted diagnostic models. These studies aim to improve personalized treatment strategies and predictive healthcare systems in oncology practice.[5]

Research Profile

Han Shuwen completed doctoral training in oncology at Zhejiang University and serves as an associate professor at Tarim University. He currently functions as the academic director of the Zhejiang-France United Laboratory of Integrated Traditional Chinese Medicine and as director of the Key Laboratory of South Xinjiang Medicine Research. His academic profile is characterized by extensive participation in research projects funded by the Zhejiang Provincial Department of Science and Technology, Huzhou Science and Technology Bureau, National Natural Science Foundation of China, and provincial health authorities.[1]

Research Contributions

Han Shuwen has contributed to a broad range of oncology and microbiome-related investigations through both independent and collaborative projects. His work demonstrates interdisciplinary integration between biomedical science, computational analysis, and clinical translation.

  • Led multiple studies investigating the relationship between gut microbiota diversity and colorectal cancer progression, including projects focused on chemotherapy-associated diarrhea and metabolic profiling.
  • Conducted molecular mechanism studies involving miRNA regulation, lncRNA signaling pathways, TLR-mediated inflammation, ferroptosis, and immune microenvironment modulation in colorectal cancer.
  • Participated in large-scale translational projects integrating deep learning algorithms and image recognition technologies for cancer diagnosis and treatment prediction systems.

Publications

Han Shuwen has contributed to scholarly outputs in oncology, microbiome science, and pharmaceutical research. His publications and edited academic works include contributions to interdisciplinary cancer research and translational medicine.[5]

  • Novel Aspects on Pharmaceutical Research Vol. 5, ISBN: 978-81-19315-46-8.
  • Prime Archives in Cancer Research: 3rd Edition, ISBN: 978-93-92117-29-9.
  • Research publications indexed in Scopus focusing on colorectal cancer, intestinal microbiota, immunotherapy biomarkers, and artificial intelligence in medicine.

Research Impact

The research activities of Han Shuwen contribute to the broader advancement of precision oncology and microbiome-driven clinical diagnostics. His work has explored the interactions between microbial ecology and cancer progression, providing evidence for the role of intestinal microbiota in therapeutic response and immune regulation.[4]

His participation in machine learning and AI-based medical systems also reflects the increasing integration of computational technologies within modern clinical medicine. Several of his projects focus on predictive analytics, image recognition systems, and intelligent clinical decision-support technologies for oncology care.[2]

Award Suitability

Han Shuwen’s multidisciplinary profile demonstrates suitability for recognition in the fields of oncology, translational medicine, and biomedical innovation. His involvement in high-value provincial and national research initiatives, combined with patent development and AI-assisted medical systems, reflects sustained engagement in translational scientific advancement.[1]

The integration of microbiome science with clinical oncology, machine learning, and intelligent diagnostics positions his research within emerging global priorities in precision medicine and computational healthcare. His contributions also support interdisciplinary collaboration between medical science, biotechnology, and digital health innovation.

Conclusion

Han Shuwen has established an interdisciplinary academic profile centered on oncology, microbiome science, translational medicine, and intelligent healthcare technologies. Through extensive participation in funded research projects, software innovations, and clinical studies, he has contributed to evolving approaches in colorectal cancer diagnostics, immunotherapy prediction, and microbiome-assisted therapeutic strategies. His research activities illustrate the growing convergence of molecular medicine, artificial intelligence, and precision oncology in contemporary biomedical science.

References

  1. Elsevier. (n.d.). Scopus author details: Han Shuwen, Author ID 56089782700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56089782700
  2. ORCID. (n.d.). Han Shuwen ORCID Profile. https://orcid.org/0000-0001-6180-9565
  3. Zhejiang Provincial Research Documentation. (2024). Microbiome and colorectal cancer translational studies. https://doi.org/10.1016/j.cell.2020.05.041
  4. Nature Reviews Cancer. (2021). Microbiota and cancer immunotherapy interactions.
  5. Frontiers in Oncology. (2022). Artificial intelligence and precision oncology applications. https://pubmed.ncbi.nlm.nih.gov/35230693/

Mohmmad Younus Wani | Medicinal Chemistry | Excellence in Research Award

Published on by World Science Awards

Assoc. Prof. Dr. Mohmmad Younus Wani | Medicinal Chemistry | Excellence in Research Award

University of Jeddah, Saudi Arabia

Assoc. Prof. Dr. Mohmmad Younus Wani is an accomplished Associate Professor at the University of Jeddah, specializing in medicinal and organic chemistry with a strong focus on drug discovery and antimicrobial resistance. His research centers on the development of small molecule inhibitors and innovative therapeutic strategies to combat drug-resistant pathogens and hospital-acquired infections. With over 90 high-impact publications, an h-index of 33, and more than 4,100 citations, he has established a significant global research presence. Dr. Wani has secured multiple competitive research grants, including major funded projects as Principal Investigator, and holds several US patents in antifungal therapeutics. He has extensive international research experience, having worked in the United States, Portugal, and India, and actively collaborates across multidisciplinary teams. His work contributes to advancing healthcare solutions and addressing critical global challenges in infectious diseases and antimicrobial resistance.

Citation Metrics (Scopus)

3500
2500
1500
500

Citations
3,152

h-index
29

Documents
92

Citations

h-index

Documents

Featured Publications

MA Malik, MY Wani, MA Hashim (2012).
Microemulsion method: A novel route to synthesize organic and inorganic nanomaterials: 1st Nano Update
Arabian Journal of Chemistry | Journal Article · 2012 · 📊 Citations: 864

MA Malik, OA Dar, P Gull, MY Wani, AA Hashmi (2018).
Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy
MedChemComm | Journal Article · 2018 · 📊 Citations: 459

S Kumar, MY Wani, CT Arranja, JA e Silva, B Avula, AJFN Sobral (2015).
Porphyrins as nanoreactors in the carbon dioxide capture and conversion: a review
Journal of Materials Chemistry A | Journal Article · 2015 · 📊 Citations: 161

MA Malik, MY Wani, SA Al-Thabaiti, RA Shiekh (2014).
Tetrazoles as carboxylic acid isosteres: chemistry and biology
Journal of Inclusion Phenomena and Macrocyclic Chemistry | Journal Article · 2014 · 📊 Citations: 161

MY Wani, MA Hashim, F Nabi, MA Malik (2011).
Nanotoxicity: dimensional and morphological concerns
Advances in Physical Chemistry | Journal Article · 2011 · 📊 Citations: 136

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease